Merck logo

Latest headlines

Merck News

The latest Merck (MRK) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these MRK headlines next to the live Merck Fear and Greed Index.

Latest Merck Headlines37

Merck Stock Hits New 52-Week High: What's Driving the Rally?

zacks.com · Aug 26, 2026

Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus

fool.com · Aug 26, 2026

3 Dividend Stocks to Hold for the Next 10 Years

fool.com · Aug 25, 2026

Explainer: How the Merck/Moderna cancer vaccine works and possible barriers to wide use

reuters.com · Aug 25, 2026

What Happens if Moderna's Cancer Vaccine Works

barrons.com · Aug 25, 2026

Why Is Merck Stock Still An Undervalued Mega-Cap In Pharma?

forbes.com · Aug 21, 2026

Can Merck's New Drugs Offer Growth Cushion Ahead of Keytruda LOE?

zacks.com · Aug 21, 2026

COVID-19 Made Moderna Famous: Cancer Could Define Its Future

benzinga.com · Aug 21, 2026

Merck vs. J&J: Which Healthcare Giant Should Investors Choose?

zacks.com · Aug 21, 2026

Breakfast News: Week in Review

fool.com · Aug 21, 2026

Merck Slips After 12.6% Cancer-Vaccine Surge

gurufocus.com · Aug 20, 2026

MRK/MRNA's Personalized Cancer Therapy Delivers First Phase III Win

zacks.com · Aug 20, 2026

Moderna is paring back gains, but Merck stock remains a buy

invezz.com · Aug 20, 2026

Thursday's First Moves: Analysts Mixed on MRNA & MRK Rally, AAP & DE Earnings

youtube.com · Aug 20, 2026

Moderna Stock Rockets Higher After Positive Cancer Vaccine Trial Data

investopedia.com · Aug 20, 2026

This Merck Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

benzinga.com · Aug 20, 2026

5 Things to Know Before the Stock Market Opens on Thursday

investopedia.com · Aug 20, 2026

Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For

benzinga.com · Aug 19, 2026

Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?

zacks.com · Aug 19, 2026

Stock Market Today, Aug. 19: Stocks Edge Higher, Ending 3-Day Losing Streak

fool.com · Aug 19, 2026

Moderna, Merck breakthrough could usher in wave of cancer vaccines

reuters.com · Aug 19, 2026

Merck Just Raised the Stakes for Pfizer's Cancer Vaccine Ambitions

benzinga.com · Aug 19, 2026

From COVID to Cancer: Moderna Scores Melanoma Breakthrough

zacks.com · Aug 19, 2026

Broadcom Drags the Nasdaq While the Dow and S&P 500 Climb

fool.com · Aug 19, 2026

Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors.

fool.com · Aug 19, 2026

Moderna Stock Surges on Stunning Cancer Update

gurufocus.com · Aug 19, 2026

Merck Soars On Cancer Vaccine Trial Win With Moderna, More Upside Ahead

seekingalpha.com · Aug 19, 2026

Merck: Why Consolidation Looks Like The Next Move (Rating Downgrade)

seekingalpha.com · Aug 19, 2026

Earnings, Cancer Vaccine, Long-Term Liquidity: A Busy Pre-Market

zacks.com · Aug 19, 2026

Moderna's Cancer Vaccine Win Is Merck's Story Too

benzinga.com · Aug 19, 2026

Moderna shares soar as mRNA cancer vaccine succeeds in late-stage trial

proactiveinvestors.com · Aug 19, 2026

Merck, Moderna Stocks Soar After Melanoma Trial Success

youtube.com · Aug 19, 2026

VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results

reuters.com · Aug 19, 2026

Merck, Moderna Melanoma Vaccine Study Succeeds

youtube.com · Aug 19, 2026

U.S. Treasury Boosts Debt Buybacks, UAE Cuts Off Iran, MRNA & MRK Melanoma Trial Results

youtube.com · Aug 19, 2026

'An increased ability to disease-free': Moderna CEO & Merck's Dr. Li on skin cancel vaccine trial

youtube.com · Aug 19, 2026

Merck and Moderna Release Landmark Personalized Cancer Therapy Trial Success, Stocks Soar

benzinga.com · Aug 19, 2026

Why Is Merck Up or Down Today?

When Merck (MRK) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a MRK move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Merck is up or down today.

How Merck News Affects the Price

News does not move the Merck (MRK) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Merck Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Merck trading volume. That is the chain to watch: headline, sentiment, volume, then the MRK price.

Trade the Merck News With Sentiment

Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Merck trading volume spike on a big story, check the Merck price history for context, follow the live MRK price, see the Merck price prediction, and read the Merck Fear and Greed Index for mood.

How do you feel about Merck?

1D

Frequently asked questions

Why is Merck up or down today?
Merck (MRK) moves on news, and the headlines above are the fastest way to see what is driving MRK today, from earnings, guidance and analyst moves to the broader market mood. Cross-check the reaction against the live Merck Fear and Greed Index and MRK trading volume.
What is the latest Merck news?
The newest Merck (MRK) headlines are listed above, most recent first, each linking to the original source. We pull the last 60 stories so you can scroll the full recent MRK news cycle in one place.
Where does Merck news come from?
We aggregate Merck (MRK) headlines from financial news wires and refresh them continuously. Each headline links straight to the original source.
How often is Merck news updated?
Continuously. The Merck (MRK) feed refreshes as new stories are published, so the headlines at the top are the freshest available.
How does Merck news relate to its Fear and Greed Index?
News drives sentiment, and sentiment drives price. A run of negative headlines tends to push the Merck Fear and Greed Index toward fear, positive coverage toward greed. Reading them together is how you separate noise from a real shift in mood.

Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.

About CFGI

The per-asset sentiment record.

CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.

Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.